We earn commissions from the providers listed here. No provider buys a position, a rating, or a listing. The order is set by hand, and we do not claim it is independent of what we earn. Advertising Disclosure
Written by Jess TranContributing Writer
Updated on
Hair Loss Treatment in Washington D.C.All 8 Providers Compared for 2026
In Washington D.C., you can get hair loss prescriptions online without a video visit. None of the eight platforms bills insurance, so plan on paying out of pocket.
Fast Approval
Free Shipping
Exclusive Coupons
Online Prescription
Key Takeaways
Best hair loss treatment telehealth in Washington D.C.: Strut and Hims (both 9.4/10 rating). Washington D.C. has full telehealth parity laws, but none of the eight platforms bills your insurer, so both the visit and the medication are out of pocket. Eight providers operate in D.C. in 2026.
Who This Is For
This is for
You live in Washington D.C. and want a prescription from a licensed D.C. provider without visiting a clinic.
You are fine paying out of pocket, since none of the eight platforms bills your insurer for hair loss care.
With 8 providers available in D.C., you can compare plans, pricing, and treatment types before committing.
Not for
Washington D.C. requires prescriptions from a licensed D.C. provider, so out-of-state prescriptions cannot be used here.
Not for you if you are unwilling to complete a telehealth consultation - no D.C. provider on this page offers walk-in or in-person visits.
If your hair loss is patchy, came on suddenly, or came with scalp scarring, say so at intake, because the cause changes what a prescriber can treat remotely.
A remote visit cannot include a physical exam or in-office testing. If that matters for your situation, raise it with a licensed provider before choosing a platform.
If this is an emergency, call 911 or go to the nearest emergency room. Telehealth is not for emergency care.
These notes are not a medical screening: a licensed provider decides after an intake review whether a treatment is appropriate for you.
User Preferences & Washington D.C. Availability
Hims is the top choice for 53% of users comparing hair loss providers on ManyTreatments in 2026, followed by Ro (19%) and Hers (12%).
9 licensed telehealth providers offer hair loss programs to Washington D.C. residents. Washington D.C. requires prescriptions to be written by a licensed in-state provider.
Medical Disclaimer: Content is for informational purposes only - not medical advice. Consult a licensed healthcare provider before any treatment. Learn more
FDA-approved finasteride 1mg tablets from $25/mo, approved for male pattern hair loss
HairfectRx capsules and topicals combine finasteride or dutasteride with minoxidil in one compounded formula. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Custom dutasteride capsules, 0.1mg to 0.6mg with or without biotin, are compounded and prescribed off-label for hair loss
Oral minoxidil tablets prescribed off-label; minoxidil tablets are FDA-approved for high blood pressure, not for hair loss
Prescribed online by U.S.-licensed physicians, free consultation to start
DHT-Targeting Hair Loss Treatment - HSA/FSA Accepted on Eligible Plans
Finasteride lowers DHT, the hormone behind most male pattern hair loss
Follicure RX spray combines minoxidil, topical finasteride and ketoconazole; no FDA-approved product pairs those three, and Peter MD does not publish whether it is compounded
ReGenX Bundle pairs 60 finasteride 1mg tablets with a 50mL bottle of Follicure RX spray
9.5 (Exceptional) in our ratings - FSA/HSA payments accepted on eligible plans
9.5
ExceptionalScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
Minoxidil From $12.67/mo - FDA-Approved Hair Regrowth
Minoxidil 2% topical solution from $12.67/mo; oral minoxidil from $29/mo, prescribed off-label for hair loss
Biotin + Minoxidil gummies and chews from $35/mo, compounded Hair Blends that carry no FDA approval and no FDA review of safety, effectiveness or quality
Postmenopausal serum pairing finasteride with minoxidil, a compounded blend; no topical finasteride product is FDA-approved
Topical minoxidil holds FDA approval for women's hair regrowth; the multi-ingredient blends do not
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
FDA-Approved Finasteride and Minoxidil - 100% Online, Free Shipping
Finasteride and minoxidil, plus the compounded Hair Hybrids blends, which the FDA has neither approved nor reviewed for safety, effectiveness, or quality
Oral finasteride tablets and topical minoxidil hold FDA approval for hair loss; the spray, chew and serum blends are the compounded Hair Hybrids and do not
Initial evaluation, ongoing check-ins and provider questions at no extra cost
Free shipping to your door - no insurance needed
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
Oral Hair Protocols From $24.99/mo - HSA and FSA Accepted
Oral minoxidil from $24.99/mo, oral dutasteride from $34.99/mo, and a topical Minoxidil+ gel from $44.99/mo
Combination protocols pair an oral DHT blocker with a targeted topical gel, from $59.99/mo
Compounded gels combine dutasteride, minoxidil, tretinoin and fexofenadine; compounded formulas are prepared by a licensed pharmacy and are not reviewed by the FDA
Available in all 50 states, HSA and FSA accepted, free discreet shipping
FDA-Approved Finasteride and Minoxidil - 100% Online, Free Shipping
Finasteride and minoxidil, plus the compounded Hair Hybrids blends, which the FDA has neither approved nor reviewed for safety, effectiveness, or quality
Oral finasteride tablets and topical minoxidil hold FDA approval for hair loss; the spray, chew and serum blends are the compounded Hair Hybrids and do not
Initial evaluation, ongoing check-ins and provider questions at no extra cost
This hair loss provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, and service areas. Our ratings are editorial judgments, not tallies of reviews.
Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers
Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.
Independent ResearchNo paid placements
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated October 6, 2026
Licensed Providers OnlyAll listed services are US-licensed
Hair Loss Treatment in Washington D.C.: All 8 Providers Compared for 2026
Written by Jess TranContributing Writer
17 min readUpdated October 6, 2026
8 hair loss telehealth providers serve Washington D.C. in 2026. Compare Strut, Hims, Ro, and more - with D.C. insurance parity, pricing, and medication details.
Which Hair Loss Providers Actually Operate in Washington D.C.
Eight telehealth platforms currently offer hair loss treatment to Washington D.C. residents: Hims, Hers, Ro, Strut, Peter MD, Sesame Care, Maximus, and Nutrafol. That is a solid lineup, but two names you may have seen recommended elsewhere are not available here. Keeps and Nurx are not among the platforms compared on this page for Washington D.C., so if you found a review pointing you toward either of those, check keeps.com or nurx.com directly to confirm what they actually offer.
The fact that you have eight options is actually good news, because it means real competition. You are not stuck with one or two platforms that can charge whatever they want. The providers serving D.C. range from compounding-pharmacy-backed specialists like Strut to large general-purpose platforms like Hims and Ro, to a transparent pay-per-visit marketplace in Sesame Care. The right pick depends heavily on whether you are a man or woman, whether you want to use insurance, and how much customization you want in your treatment.
Washington D.C.'s Insurance Parity Laws Change the Math on Telehealth Hair Loss Treatment
Washington D.C. has full insurance parity for telehealth, which means an insurer must cover a video visit at the same rate it covers the same visit in person. That rule binds insurers, not platforms, and none of the eight compared here submits a claim to one, so it does not change what you pay on any of them. Where it matters is if you see an in-network D.C. dermatologist who offers video appointments.
For women in D.C., the parity rules go even further. D.C. Medicaid covers broader preventive care for women, including visits related to hair loss when it is connected to hormonal or systemic health concerns. If you are on Medicaid and dealing with hair thinning related to hormonal changes, it is worth calling your plan before you assume nothing is covered. None of the eight platforms bills your insurer for hair loss treatment, so the parity law does not change what any of them charges you.
The practical takeaway is this: D.C.'s parity law governs what an insurer must do, and none of the eight platforms here bills an insurer, so budget for both the consultation and the medication as direct-pay costs. If you want to use coverage, the realistic route is an in-network D.C. dermatologist who offers video visits, not a subscription platform.
What Hair Loss Medications You Can Actually Get in Washington D.C.
Washington D.C. follows federal prescription requirements without adding extra state-level restrictions on hair loss medications. Finasteride and oral minoxidil are both prescription-only here, which means you need a licensed clinician to prescribe them regardless of which platform you use. Topical minoxidil, the kind sold as Rogaine or its generics, is available over the counter at any CVS or Walgreens in D.C. without a prescription. If you just want to start topical minoxidil tonight, you do not need any of these platforms at all.
For anything beyond basic topical minoxidil, telehealth is genuinely the fastest path. Finasteride (1mg for hair loss) is FDA-approved for men and widely prescribed through Hims, Ro, Peter MD, and Strut. Oral minoxidil at low doses (0.625mg to 2.5mg) has become a more popular option in recent years and is available through most of these platforms off-label. Dutasteride is also off-label for hair loss in D.C. and is not offered by every platform, but Strut specifically includes it as part of their compounded formulations. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Women in D.C. have access to spironolactone through platforms like Hers, which is the primary prescription option for female pattern hair loss and androgenetic alopecia in women. Spironolactone requires a bit more upfront screening than finasteride does for men, particularly around blood pressure and potassium levels, but Hers handles this within their intake process. Nutrafol takes a different angle entirely with clinician-prescribed supplements and topicals backed by clinical data, which appeals to women who want to avoid prescription medications or who are pregnant or planning to be.
The Best Hair Loss Provider in Washington D.C. Depends on What You Actually Need
Strut earns the top rating in D.C. at 9.4/10, and the reason it stands out is the compounding pharmacy model. Instead of prescribing you a standard finasteride tablet and sending you on your way, Strut can combine finasteride and minoxidil into a single topical compound tailored to your specific situation. This matters because some men get better results from a combination approach, and getting both ingredients in one application reduces friction. If you want the most customized hair loss treatment available by telehealth in D.C., Strut is the answer. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Hims matches Strut's 9.4/10 rating and serves a different kind of buyer. Hims is built for simplicity and affordability. Generic finasteride through Hims runs around $22 to $30 per month, and the mobile experience is genuinely better than most competitors. If you are a man who knows he wants finasteride or a basic minoxidil product and you want to get started quickly without a lot of back-and-forth, Hims is the fastest path.
Ro sits at 9.3/10 and is the platform to consider if you are dealing with multiple health concerns at once. Ro has actual insurance navigation built in for several treatments, and while hair loss medications are largely not covered by insurance as a category, Ro's clinical team is set up to help you understand what might qualify. For someone managing both hair loss and another condition like weight gain or hormonal changes, Ro's breadth is an advantage.
Peter MD comes in at 9.5/10. It is a men's-only platform with physician-led protocols, and at $60 a month it costs more than the generic-focused platforms here. If you want a men's-only clinical experience, Peter MD is worth a close look. Hers at 9.1/10 is the equivalent recommendation for women, covering hair loss alongside birth control, mental health, and weight management in a single platform.
What Hair Loss Treatment Actually Costs in Washington D.C. in 2026
Generic finasteride is the cheapest prescription option available through telehealth in D.C. Hims prices it around $22 to $30 per month. Peter MD's hair loss program starts at $60 a month, so it costs more than the generic route. The consultation fee varies by platform, but several providers fold the consultation cost into the first month's subscription, so you are not paying $75 upfront just to talk to someone before you can buy anything.
Compounded finasteride-minoxidil topicals from Strut run higher, typically in the $60 to $90 per month range depending on the formulation. That sounds like more, but you are getting a single product that replaces what would otherwise be two separate prescriptions. For some people that math works out, and for others the simplicity alone is worth the difference. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Nutrafol is the priciest option in the D.C. lineup at roughly $88 to $99 per month for the supplement-based approach. That is without insurance, and supplements are almost never covered. The trade-off is that Nutrafol's products have clinical studies behind them and are appropriate for people who cannot or do not want to take prescription medications. Sesame Care prices differently from everyone else because it is pay-per-visit rather than subscription-based. A single hair loss consultation on Sesame Care might run $50 to $75, and then you take that prescription to any pharmacy you choose. If you already know what you want and just need a licensed clinician to write the prescription, Sesame Care is worth considering specifically because you are not locking into a monthly plan.
Hair Loss Treatment for Women in Washington D.C.: What the Platforms Don't Always Tell You
Several of the eight platforms serving D.C. are men-only or treat women as an afterthought. Maximus and Peter MD are both men's health focused. Hims has a separate women's brand entirely, which is Hers. If you are a woman researching hair loss treatment in D.C., your most relevant options are Hers, Nutrafol, Sesame Care, and Ro. Strut also treats women for hair loss, which makes it one of the more genuinely cross-gender platforms in the group.
Female pattern hair loss and androgenetic alopecia in women often involve hormonal contributors that male-pattern baldness does not. Spironolactone, which is an androgen blocker originally used for blood pressure, is one of the most commonly prescribed medications for women with hair loss in D.C. Hers can prescribe it. Oral minoxidil at very low doses is also gaining traction for women, and Hers and Ro both have protocols for it. The intake questionnaire for women typically includes questions about your cycle, any hormonal conditions, pregnancy status, and blood pressure, so have that information ready.
D.C.'s full insurance parity for women's telehealth visits is directly relevant here. Hers does not bill your insurer, though, so parity does not lower what you pay there. It matters if you see an in-network D.C. clinician by video instead of in person. It is one of the more practical advantages of being in D.C. compared to states like Florida or Texas where parity rules are weaker.
A Washington D.C.-Specific Reality: Federal Employees and FEHB Coverage for Hair Loss
A large segment of Washington D.C. residents are federal employees or contractors covered under the Federal Employees Health Benefits program. FEHB plans vary significantly, but most cover telehealth visits for primary care and some specialty consultations. Hair loss medications themselves, particularly finasteride and minoxidil, are almost universally excluded from FEHB coverage as cosmetic or non-medically-necessary treatments. The visit to get the prescription, however, is a different story.
If you are covered under a FEHB plan, note that none of the eight platforms here bills your insurer, so the consultation is a direct-pay cost whichever one you choose. Check whether your specific FEHB plan includes a health savings account or flexible spending account that could be used for eligible hair loss prescriptions, since finasteride prescribed for a recognized medical condition can sometimes qualify.
This is not something you will read on a generic telehealth comparison page, but if you work for a federal agency or a D.C.-area contractor with FEHB coverage, it is directly relevant to how you should approach starting treatment. None of the platforms here bills your insurer for the visit or the medication, so treat the whole cost as direct-pay.
Making the Call: Which Washington D.C. Hair Loss Platform Is Right for You
If you want the highest-rated platform with the most customized formulations, Strut is the answer. It holds a 9.4/10 rating, is backed by a real compounding pharmacy, and can combine finasteride and minoxidil in a single topical compound. It treats both men and women, which most of the male-focused platforms do not. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
If you are a man who wants to start fast and keep costs low, Hims is the most straightforward choice. Generic finasteride at around $22 to $30 per month and a clean mobile app make it easy to trust. If you want a physician-led experience built specifically for men, Peter MD is the D.C. option to look at, at $60 a month.
If you have insurance and want to use it, remember that none of the eight platforms bills your insurer at all, so an in-network D.C. dermatologist offering video visits is the only route where parity changes what you pay. If you want maximum transparency and zero subscription commitment, Sesame Care's pay-per-visit model lets you get a consultation and prescription without signing up for anything ongoing. For women specifically, Hers is the most purpose-built option and handles spironolactone and minoxidil prescriptions within a platform designed around women's health from the ground up.
What to Expect When You Start Hair Loss Treatment Through Telehealth in Washington D.C.
Every platform starts with an intake questionnaire. For hair loss, you will typically answer questions about when the shedding started, whether it is diffuse or patterned, any family history of hair loss, medications you currently take, and relevant health conditions. Some platforms ask you to upload photos of your scalp from specific angles. This is not vanity, it genuinely helps the clinician assess your hair loss pattern and recommend an appropriate starting point. Have good lighting and take the photos before you start the intake.
After the questionnaire, a licensed clinician in Washington D.C. reviews your information and either approves a prescription or follows up with questions. On platforms like Hims and Hers, this happens asynchronously, meaning the clinician reviews your case on their schedule and you get a response within a few hours. On Sesame Care, you can also schedule a live video visit if you prefer that format.
Once prescribed, your medication ships directly to your D.C. address or is sent electronically to a local pharmacy if you prefer to pick it up. Finasteride takes three to six months to show noticeable results, so do not judge the treatment by month one. Minoxidil often causes a temporary shedding phase in the first four to eight weeks as hair follicles cycle. This is normal and not a sign the treatment is failing, but it catches a lot of people off guard. Knowing about it beforehand makes it much easier to stay the course.
Frequently Asked Questions
Which hair loss providers aren't compared on this Washington D.C. page?
Keeps and Nurx are not among the eight platforms compared on this page for Washington D.C. If you have seen either of those recommended in a general telehealth guide, check keeps.com or nurx.com directly rather than relying on this page for them. The eight providers compared here are Hims, Hers, Ro, Strut, Peter MD, Sesame Care, Maximus, and Nutrafol. That gives you meaningful options across price points and specializations, from compounding-pharmacy formulations at Strut to pay-per-visit consultations at Sesame Care. None of the eight compared here require you to be in a specific D.C. zip code, so whether you are in Capitol Hill, Georgetown, or Anacostia, you can access all eight.
Does insurance cover hair loss treatment in Washington D.C.?
Washington D.C. has full telehealth parity, which binds insurers rather than platforms. The medications themselves, finasteride, minoxidil, and spironolactone, are almost always classified as cosmetic or non-medically-necessary and excluded from drug coverage. None of the eight platforms here bills your insurer at all, for the medication or the visit, so both are direct-pay costs regardless of the parity law. If you are on D.C. Medicaid, it is worth calling your plan because broader preventive women's health coverage sometimes extends to visits where hair loss is a presenting concern connected to a hormonal condition.
Can I get finasteride online in Washington D.C.?
Yes. Finasteride is available through telehealth in Washington D.C. and is offered by Hims, Ro, Strut, Peter MD, and Sesame Care. It is prescription-only in D.C., so you cannot buy it without a licensed clinician approving your case. The process is straightforward: complete an intake questionnaire, upload scalp photos, get reviewed by a clinician, and receive your prescription either by mail or sent to a local pharmacy. Generic finasteride through Hims runs roughly $22 to $30 per month, making it the most affordable prescription hair loss treatment available in D.C. through telehealth.
Is oral minoxidil available through telehealth in Washington D.C.?
Yes, oral minoxidil is available in Washington D.C. through telehealth, though it is prescribed off-label for hair loss. It is not FDA-approved for that indication specifically, but it is increasingly common in clinical practice at low doses, typically 0.625mg to 2.5mg. Platforms including Hims, Ro, Hers, and Strut can prescribe it after reviewing your health history. Because it is a blood pressure medication at higher doses, the intake process will ask about your cardiovascular history and current medications. Topical minoxidil (Rogaine) remains available over the counter at any D.C. pharmacy without a prescription if you want to start something immediately.
What is the cheapest hair loss treatment available in Washington D.C.?
The cheapest prescription hair loss treatment in Washington D.C. in 2026 is generic finasteride, available through Hims for roughly $22 to $30 per month, with a clean app experience. Peter MD is structured specifically for men, though at $60 a month it costs more than the generic route. If you want to avoid a subscription entirely, Sesame Care offers pay-per-visit consultations where you pay $50 to $75 for the clinical visit and then take your prescription to any pharmacy you choose, which gives you full price control on the medication side. Topical minoxidil over the counter is technically the cheapest option of all, starting around $20 for a month's supply at any D.C. pharmacy.
Which hair loss platform is best for women in Washington D.C.?
Hers is the most purpose-built platform for women dealing with hair loss in Washington D.C. It covers spironolactone prescriptions, oral and topical minoxidil, and handles the additional screening that women's hair loss treatment requires, including questions about hormones, menstrual cycle, and blood pressure. Hers has a 9.1/10 rating. Strut also treats women and can create compounded formulations. Nutrafol is the best option for women who want a supplement and topical approach without prescription medications, particularly if you are pregnant or planning to be. None of the eight platforms bills your insurer, so the consultation and the medication are both out of pocket. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
How long does it take to see results from hair loss treatment in Washington D.C.?
Regardless of which D.C. platform you use, the medication timeline is the same. Finasteride generally takes three to six months before you notice a meaningful reduction in shedding or any regrowth. Minoxidil, whether oral or topical, often causes a temporary increase in shedding for the first four to eight weeks as hair follicles transition between growth phases. This is a known side effect, not a sign the treatment is failing. Most clinicians ask you to commit to at least six months before evaluating whether a treatment is working. Hair loss treatment is genuinely a slow game, and the platforms that set realistic expectations upfront, like Strut and Ro, tend to retain subscribers better because people are not surprised when month one looks worse before it looks better.
Can federal employees in Washington D.C. use FEHB insurance for hair loss telehealth visits?
None of the eight platforms compared here bills FEHB, or any other insurer, for a hair loss consultation, so the visit is a direct-pay cost. FEHB drug coverage almost universally excludes finasteride and minoxidil for hair loss as non-medically-necessary, so the medication is out of pocket as well. Ro has more insurance navigation support than most of the other platforms, though none bill FEHB directly for the medication itself. Federal employees should also check whether their FEHB plan includes an FSA or HSA that could cover finasteride or minoxidil costs when prescribed for a recognized medical condition, since this varies by plan.
Is dutasteride available for hair loss through telehealth in Washington D.C.?
Dutasteride is available off-label for hair loss in Washington D.C. but is not offered by every telehealth platform. Strut is the most accessible D.C. provider for dutasteride because it can incorporate it into compounded formulations. Ro also has the clinical breadth to prescribe it off-label. Dutasteride is a stronger DHT blocker than finasteride and is sometimes recommended for men who have not responded adequately to finasteride after six months. Because it is off-label, you should expect a more detailed screening conversation about why the standard first-line option was not sufficient. It is not typically offered to first-time hair loss treatment seekers without a documented history. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
What is the top-rated hair loss platform in Washington D.C. right now?
Strut and Hims are tied for the second-highest rating among hair loss providers in Washington D.C., both at 9.4/10, just behind category leader Peter MD at 9.5/10. Strut leads on customization and compounding, making it the top pick if you want a tailored treatment plan, a combination formulation, or treatment as a woman. Hims leads on simplicity, pricing, and mobile experience, making it the top pick if you are a man who wants to start quickly with minimal friction. Both are strong picks in D.C.'s provider lineup for 2026, and which one is right for you comes down to whether your priority is personalization or convenience. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage you to verify information with authoritative sources.
CCHP Telehealth Policy - Washington D.C.Washington D.C. state telehealth laws, online prescribing rules, and insurance reimbursement policies maintained by the Center for Connected Health Policy.
PMC - Male and Female Pattern Hair Loss2025 clinical review on androgenetic alopecia in men and women: presentation differences, spironolactone for women, and treatment evidence levels.
PMC - Alopecia Therapy Update2023 peer-reviewed therapy update on androgenetic alopecia: FDA-approved treatments, PRP, low-level light therapy, and compounded formulations.
AAD - Hair Loss and AlopeciaAmerican Academy of Dermatology overview of alopecia types, clinical presentation, and evidence-based treatment recommendations.
NIMH - Mental Illness StatisticsNIMH data: 1 in 5 U.S. adults experience mental illness annually. National prevalence by condition, age, and demographic.
NIH - Androgenetic Alopecia (StatPearls)NIH clinical reference: androgenetic alopecia affects up to 80% of men by age 80. Covers DHT mechanism, finasteride, and minoxidil as FDA-approved treatments.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
FDA-Approved Finasteride and Minoxidil - 100% Online, Free Shipping
Finasteride and minoxidil, plus the compounded Hair Hybrids blends, which the FDA has neither approved nor reviewed for safety, effectiveness, or quality
Oral finasteride tablets and topical minoxidil hold FDA approval for hair loss; the spray, chew and serum blends are the compounded Hair Hybrids and do not
Initial evaluation, ongoing check-ins and provider questions at no extra cost
Jess Tran is a content writer and researcher who covers weight loss, hair loss, and online health services. She describes her job as reading the fine print so you never have to, which her friends find either impressive or deeply concerning depending on the day. Jess has strong opinions about poorly designed apps, overpriced supplements, and good pho. When she is not writing, she is cycling around the city, hunting for the best cafe with the worst Wi-Fi, or helping kids learn to read at a local after-school program.
Medical Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. Telehealth regulations in Washington D.C. may change. Always verify requirements with your chosen provider. Read our full medical disclaimer.
Regulatory noticeRegulatory note (verified October 8, 2026): The FDA reviewed struthealth.com in December 2025 and, on February 20, 2026, issued Strut Health, LLC a warning letter, MARCS-CMS 721448. It raises two separate problems. Pictured product labels carry the "Strut" name, which the agency said represents Strut as the compounder of the semaglutide and tirzepatide products when it is not. The letter also quotes three claims from the site, among them "Generic Zepbound, Mounjaro", along with site copy naming semaglutide and tirzepatide as the active ingredient in the brand medications. Because compounded drugs hold no FDA approval, the FDA said wording of that kind implies one, and it cited misbranding under sections 502(a) and 502(bb) of the FD&C Act. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for Strut Health, LLC on October 8, 2026 it showed no response letter and no close-out letter, so we treat the matter as open. Read the FDA letter
Regulatory noticeRegulatory note (verified August 22, 2026): Hers is a brand of Hims & Hers Health, Inc., and the FDA wrote to that company twice on September 9, 2025, once for each brand. The Hers letter, MARCS-CMS 716825, went to chief executive Andrew Dudum after an August 2025 review of forhers.com. It quotes two claims made for compounded semaglutide: "Weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." The agency’s position is that compounded products carry no FDA approval, so claims like these imply a sameness with approved medicines that has not been established, making the products misbranded. FDA’s index lists neither a response nor a close-out letter, so the matter stands open. Read the FDA letter
Regulatory noticeRegulatory note (verified August 22, 2026): On September 9, 2025 the FDA sent Hims & Hers Health, Inc. a warning letter covering the Hims brand, MARCS-CMS 716567, drawn from a review of hims.com the previous month. Two lines about compounded semaglutide are quoted in it: "Same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." Compounded drug products are not FDA-approved, and the agency said phrasing of this sort suggests otherwise, which is what makes the products misbranded under FD&C Act sections 502(a) and 502(bb). A companion letter went to the same company that day for its Hers brand. No close-out letter appears in FDA’s index; treat this as open. Read the FDA letter
Regulatory noticeRegulatory note (verified August 22, 2026): A May 2026 review of maximustribe.com led the FDA to issue Maximus Health, Inc. warning letter MARCS-CMS 730095 on June 8, 2026. The language quoted here concerns effect and sourcing rather than ingredient comparison: "Clinically studied ingredients," "Clinically studied to help patients...," and "Proven to lose weight effectively," alongside a statement that the compounded products come from "FDA approved pharmacies." On that last point the agency was explicit that no FDA-approved or FDA-licensed designation exists for compounding pharmacies or outsourcing facilities, so describing one that way is misleading. Both findings were cited as misbranding under FD&C Act 502(a) and 502(bb). Nothing in FDA’s index records a close-out, so we log the matter as open. Read the FDA letter